![ESMOAsia2023_Audience_03](/var/esmo/storage/images/media/esmo-daily-reporter/images/esmo-asia-congress-2023/esmoasia2023_audience_03/18628811-1-eng-GB/esmoasia2023_audience_03_i770.jpg)
New models show promise for predicting response to treatment in HER2-positive breast cancer
Personalisation of treatment could be a step closer by integrating several cancer characteristics, but consolidation of data from these tools is needed before their use in clinical practice